{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T04:52:23Z","timestamp":1779339143525,"version":"3.51.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T00:00:00Z","timestamp":1682467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007465","name":"UiT The Arctic University of Norway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007465","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Prim. Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Urogenital cancers are common, accounting for approximately 20% of cancer incidence globally. Cancers belonging to the same organ system often present with similar symptoms, making initial management challenging. In this study, 511 cases of cancer were recorded after the date of consultation among 61,802 randomly selected patients presenting in primary care in six European countries: a subgroup analysis of urogenital cancers was carried out in order to study variation in symptom presentation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Initial data capture was by completion of standardised forms containing closed questions about symptoms recorded during the consultation. The general practitioner (GP) provided follow-up data after diagnosis, based on medical record data made after the consultation. GPs also provided free text comments about the diagnostic procedure for individual patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The most common symptoms were mainly associated with one or two specific types of cancer: \u2018Macroscopic haematuria\u2019 with bladder or renal cancer (combined sensitivity 28.3%), \u2018Increased urinary frequency\u2019 with bladder (sensitivity 13.3%) or prostatic (sensitivity 32.1%) cancer, or to uterine body (sensitivity 14.3%) cancer, \u2018Unexpected genital bleeding\u2019 with uterine cancer (cervix, sensitivity 20.0%, uterine body, sensitivity 71.4%). \u2018Distended abdomen, bloating\u2019 had sensitivity 62.5% (based on eight cases of ovarian cancer). In ovarian cancer, increased abdominal circumference and a palpable tumour also were important diagnostic elements. Specificity for \u2018Macroscopic haematuria\u2019 was 99.8% (99.7\u201399.8). PPV\u2009&gt;\u20093% was noted for \u2018Macroscopic haematuria\u2019 and bladder or renal cancer combined, for bladder cancer in male patients. In males aged 55\u201374, PPV\u2009=\u20097.1% for \u2018Macroscopic haematuria\u2019 and bladder cancer. Abdominal pain was an infrequent symptom in urogenital cancers.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Most types of urogenital cancer present with rather specific symptoms. If the GP considers ovarian cancer, increased abdominal circumference should be actively determined. Several cases were clarified through the GP\u2019s clinical examination, or laboratory investigations.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12875-023-02063-z","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T08:02:39Z","timestamp":1682496159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Symptoms and signs of urogenital cancer in primary care"],"prefix":"10.1186","volume":"24","author":[{"given":"Knut","family":"Holtedahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Borgquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9 A.","family":"Donker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Buntinx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rgen","family":"M\u00e5nsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Hammersley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonje","family":"Braaten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranjan","family":"Parajuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,26]]},"reference":[{"issue":"6","key":"2063_CR1","doi-asserted-by":"publisher","first-page":"e00328","DOI":"10.1016\/j.heliyon.2017.e00328","volume":"3","author":"K Holtedahl","year":"2017","unstructured":"Holtedahl K, Vedsted P, Borgquist L, Donker GA, Buntinx F, Weller D, et al. Abdominal symptoms in general practice: frequency, cancer suspicions raised, and actions taken by GPs in six European countries. cohort study with prospective registration of cancer. Heliyon. 2017;3(6):e00328.","journal-title":"Heliyon"},{"issue":"670","key":"2063_CR2","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.3399\/bjgp18X695777","volume":"68","author":"K Holtedahl","year":"2018","unstructured":"Holtedahl K, Hjertholm P, Borgquist L, Donker GA, Buntinx F, Weller D, et al. Abdominal symptoms and cancer in the abdomen: prospective cohort study in European primary care. Br J Gen Pract. 2018;68(670):e301\u201310.","journal-title":"Br J Gen Pract."},{"issue":"1","key":"2063_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12875-021-01452-6","volume":"22","author":"K Holtedahl","year":"2021","unstructured":"Holtedahl K, Borgquist L, Donker GA, Buntinx F, Weller D, Campbell C, et al. Symptoms and signs of colorectal cancer, with differences between proximal and distal colon cancer: a prospective cohort study of diagnostic accuracy in primary care. BMC Fam Pract. 2021;22(1):148.","journal-title":"BMC Fam Pract."},{"issue":"6","key":"2063_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin."},{"key":"2063_CR5","unstructured":"Suspected cancer: recognition and referral. NICE guideline [NG12]. London: National Institute for Health and Care Excellence; 2015."},{"key":"2063_CR6","unstructured":"Cancer NCCf. Bladder cancer: diagnosis and management. NICE guideline [NG2], 2015. 2018."},{"key":"2063_CR7","unstructured":"Health NIf, Excellence C. Prostate cancer diagnosis and management. NICE guideline [NG131]. 2019."},{"issue":"3","key":"2063_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. GlobalCancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin."},{"issue":"9","key":"2063_CR9","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1007\/s12325-018-0766-1","volume":"35","author":"SWD Merriel","year":"2018","unstructured":"Merriel SWD, Funston G, Hamilton W. Prostate Cancer in Primary Care. Adv Ther. 2018;35(9):1285\u201394.","journal-title":"Adv Ther."},{"issue":"640","key":"2063_CR10","doi-asserted-by":"publisher","first-page":"e769","DOI":"10.3399\/bjgp15X687421","volume":"65","author":"M Schmidt-Hansen","year":"2015","unstructured":"Schmidt-Hansen M, Berendse S, Hamilton W. The association between symptoms andbladder or renal tract cancer in primary care: a systematic review. Br J Gen Pract. 2015;65(640):e769-75.","journal-title":"Br J Gen Pract."},{"issue":"4","key":"2063_CR11","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00345-019-02841-4","volume":"38","author":"V Sell","year":"2020","unstructured":"Sell V, Ettala O, Montoya Perez I, J\u00e4rvinen R, Pekkarinen T, Vaarala M, et al. Symptoms and diagnostic delays in bladder cancer with high risk of recurrence: results from a prospective FinnBladder 9 trial. World J Urol. 2020;38(4):1001\u20137.","journal-title":"World J Urol."},{"issue":"4","key":"2063_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/sajc.sajc_311_18","volume":"8","author":"A Basu","year":"2019","unstructured":"Basu A, Ghosh D, Mandal B, Mukherjee P, Maji A. Barriers and explanatory mechanisms in diagnostic delay in four cancers - A health-care disparity? South Asian J Cancer. 2019;8(4):221\u20135.","journal-title":"South Asian J Cancer."},{"issue":"4","key":"2063_CR13","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s12325-018-0683-3","volume":"35","author":"G Funston","year":"2018","unstructured":"Funston G, O\u2019Flynn H, Ryan NAJ, Hamilton W, Crosbie EJ. Recognizing Gynecological Cancer in Primary Care: Risk Factors, Red Flags, and Referrals. Adv Ther. 2018;35(4):577\u201389.","journal-title":"Adv Ther."},{"issue":"2","key":"2063_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/fampra\/cms065","volume":"30","author":"SG Ingebrigtsen","year":"2013","unstructured":"Ingebrigtsen SG, Scheel BI, Hart B, Thorsen T, Holtedahl K. Frequency of \u201cwarning signs of cancer\u201d in Norwegian general practice, with prospective recording of subsequent cancer. Fam Pract. 2013;30(2):153\u201360.","journal-title":"Fam Pract."},{"key":"2063_CR15","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1756-0500-2-200","volume":"2","author":"L Demagny","year":"2009","unstructured":"Demagny L, Holtedahl K, Bachimont J, Thorsen T, Letourmy A, Bungener M. General practitioners\u2019 role in cancer care: a French-Norwegian study. BMC Res Notes. 2009;2:200.","journal-title":"BMC Res Notes."},{"issue":"3","key":"2063_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3109\/02813432.2015.1067512","volume":"33","author":"BI Scheel","year":"2015","unstructured":"Scheel BI, Holtedahl K. Symptoms, signs, and tests: The general practitioner\u2019s comprehensive approach towards a cancer diagnosis. Scand J Prim Health Care. 2015;33(3):170\u20137.","journal-title":"Scand J Prim Health Care."},{"issue":"12","key":"2063_CR17","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1373\/clinchem.2015.246280","volume":"61","author":"PM Bossuyt","year":"2015","unstructured":"Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig L, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. Clin chemist. 2015;61(12):1446\u201352.","journal-title":"Clin chemist."},{"key":"2063_CR18","unstructured":"Cancer in Norway 2019. Cancer incidence, mortality, survival and prevalence in Norway. The Cancer Registry of Norway. 2020."},{"key":"2063_CR19","doi-asserted-by":"crossref","unstructured":"Hamilton W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. Br J Cancer. 2009;101 Suppl 2(Suppl 2):S80\u20136.","DOI":"10.1038\/sj.bjc.6605396"},{"issue":"582","key":"2063_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3399\/bjgp11X548974","volume":"61","author":"F Buntinx","year":"2011","unstructured":"Buntinx F, Mant D, Van den Bruel A, Donner-Banzhof N, Dinant GJ. Dealing with low-incidence serious diseases in general practice. Br J Gen Pract. 2011;61(582):43\u20136.","journal-title":"Br J Gen Pract."},{"key":"2063_CR21","doi-asserted-by":"publisher","first-page":"g4474","DOI":"10.1136\/bmj.g4474","volume":"349","author":"JM Hollingsworth","year":"2014","unstructured":"Hollingsworth JM, Wilt TJ. Lower urinary tract symptoms in men. Bmj. 2014;349:g4474.","journal-title":"Bmj."},{"issue":"12","key":"2063_CR22","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S1470-2045(15)00205-3","volume":"16","author":"G Rubin","year":"2015","unstructured":"Rubin G, Berendsen A, Crawford SM, Dommett R, Earle C, Emery J, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16(12):1231\u201372.","journal-title":"Lancet Oncol."},{"issue":"571","key":"2063_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3399\/bjgp10X483175","volume":"60","author":"W Hamilton","year":"2010","unstructured":"Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010;60(571):121\u20138.","journal-title":"Br J Gen Pract."},{"issue":"578","key":"2063_CR24","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.3399\/bjgp10X515412","volume":"60","author":"M Shapley","year":"2010","unstructured":"Shapley M, Mansell G, Jordan JL, Jordan KP. Positive predictive values of \u22655% inprimary care for cancer: systematic review. Br J Gen Pract. 2010;60(578):e366-77.","journal-title":"Br J Gen Pract."},{"key":"2063_CR25","unstructured":"Suspected cancer: Recognition and Referral (NICE guideline 12). London: National Institute for Health and Care Excellence. 2015."},{"issue":"1","key":"2063_CR26","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/fampra\/14.1.63","volume":"14","author":"F Buntinx","year":"1997","unstructured":"Buntinx F, Wauters H. The diagnostic value of macroscopic haematuria in diagnosing urological cancers: a meta-analysis. Fam Pract. 1997;14(1):63\u20138.","journal-title":"Fam Pract."},{"issue":"7","key":"2063_CR27","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-019-00966-x","volume":"36","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Funston G, Lyratzopoulos G, Walter FM. Improving the Timely Detection of Bladder and Kidney Cancer in Primary Care. Adv Ther. 2019;36(7):1778\u201385.","journal-title":"Adv Ther."},{"key":"2063_CR28","first-page":"g2171","volume":"348","author":"BD Nicholson","year":"2014","unstructured":"Nicholson BD, McGrath JS, Hamilton W. Bladder cancer in women. Bmj. 2014;348:g2171.","journal-title":"Bladder cancer in women. Bmj."},{"issue":"602","key":"2063_CR29","doi-asserted-by":"publisher","first-page":"e598","DOI":"10.3399\/bjgp12X654560","volume":"62","author":"EA Shephard","year":"2012","unstructured":"Shephard EA, Stapley S, Neal RD, Rose P, Walter FM, Hamilton WT. Clinical features of bladder cancer in primary care. Br J Gen Pract. 2012;62(602):e598-604.","journal-title":"Br J Gen Pract."},{"issue":"10021","key":"2063_CR30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/S0140-6736(15)00046-X","volume":"387","author":"U Capitanio","year":"2016","unstructured":"Capitanio U, Montorsi F. Renal cancer. Lancet. 2016;387(10021):894\u2013906.","journal-title":"Lancet."},{"issue":"486","key":"2063_CR31","first-page":"31","volume":"53","author":"R Bruyninckx","year":"2003","unstructured":"Bruyninckx R, Buntinx F, Aertgeerts B, Van Casteren V. The diagnostic value ofmacroscopic haematuria for the diagnosis of urological cancer in general practice. Br J Gen Pract. 2003;53(486):31\u20135.","journal-title":"Br J Gen Pract."},{"issue":"714","key":"2063_CR32","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.3399\/BJGP.2021.0282","volume":"72","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Walter FM, Mounce L, Abel GA, Singh H, Hamilton W, et al. Identifying opportunities for timely diagnosis of bladder and renal cancer via abnormal blood tests: a longitudinal linked data study. Br J Gen Pract. 2022;72(714):e19\u201325.","journal-title":"Br J Gen Pract."},{"key":"2063_CR33","doi-asserted-by":"publisher","first-page":"i5124","DOI":"10.1136\/bmj.i5124","volume":"355","author":"T Drake","year":"2016","unstructured":"Drake T, Hanna L, Davies M. Haematospermia. Bmj. 2016;355:i5124.","journal-title":"Haematospermia. Bmj."},{"issue":"10013","key":"2063_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/S0140-6736(14)61947-4","volume":"387","author":"G Attard","year":"2016","unstructured":"Attard G, Parker C, Eeles RA, Schr\u00f6der F, Tomlins SA, Tannock I, et al. Prostate cancer. Lancet. 2016;387(10013):70\u201382.","journal-title":"Lancet."},{"issue":"614","key":"2063_CR35","doi-asserted-by":"publisher","first-page":"e643","DOI":"10.3399\/bjgp13X671632","volume":"63","author":"S Walker","year":"2013","unstructured":"Walker S, Hyde C, Hamilton W. Risk of uterine cancer in symptomatic women in primary care: case-control study using electronic records. Br J Gen Pract. 2013;63(614):e643-8.","journal-title":"Br J Gen Pract."},{"issue":"10023","key":"2063_CR36","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(15)00130-0","volume":"387","author":"P Morice","year":"2016","unstructured":"Morice P, Leary A, Creutzberg C, Abu-Rustum N, Darai E. Endometrial cancer. Lancet. 2016;387(10023):1094\u2013108.","journal-title":"Lancet."},{"issue":"11","key":"2063_CR37","doi-asserted-by":"publisher","first-page":"e05372","DOI":"10.1016\/j.heliyon.2020.e05372","volume":"6","author":"S Boeckstaens","year":"2020","unstructured":"Boeckstaens S, Dewalheyns S, Heremans R, Vikram R, Timmerman D, Van den Bosch T, et al. Signs and symptoms associated with uterine cancer in pre- and postmenopausal women. Heliyon. 2020;6(11):e05372.","journal-title":"Heliyon."},{"issue":"538","key":"2063_CR38","first-page":"371","volume":"57","author":"C Parker","year":"2007","unstructured":"Parker C, Hippisley-Cox J, Coupland C, Vinogradova Y. Rectal and postmenopausal bleeding: consultation and referral of patients with and without severe mental health problems. Br J Gen Pract. 2007;57(538):371\u20136.","journal-title":"Br J Gen Pract."},{"key":"2063_CR39","first-page":"d3954","volume":"343","author":"S Saso","year":"2011","unstructured":"Saso S, Chatterjee J, Georgiou E, Ditri AM, Smith JR, Ghaem-Maghami S. Endometrial cancer. Bmj. 2011;343:d3954.","journal-title":"Endometrial cancer. Bmj."},{"issue":"6","key":"2063_CR40","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/fampra\/cmr033","volume":"28","author":"S Stapley","year":"2011","unstructured":"Stapley S, Hamilton W. Gynaecological symptoms reported by young women: examining the potential for earlier diagnosis of cervical cancer. Fam Pract. 2011;28(6):592\u20138.","journal-title":"Fam Pract."},{"key":"2063_CR41","first-page":"h4443","volume":"351","author":"S Sundar","year":"2015","unstructured":"Sundar S, Neal RD, Kehoe S. Diagnosis of ovarian cancer. Bmj. 2015;351:h4443.","journal-title":"Diagnosis of ovarian cancer. Bmj."},{"key":"2063_CR42","doi-asserted-by":"crossref","unstructured":"Herbert A, Rafiq M, Pham TM, Renzi C, Abel GA, Price S, et al. Predictive values for different cancers and inflammatory bowel disease of 6 common abdominal symptoms among more than 1.9 million primary care patients in the UK: A cohort study. PLoS Med. 2021;18(8):e1003708.","DOI":"10.1371\/journal.pmed.1003708"},{"key":"2063_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1471-2407-14-171","volume":"14","author":"KE Brain","year":"2014","unstructured":"Brain KE, Smits S, Simon AE, Forbes LJ, Roberts C, Robb\u00e9 IJ, et al. Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample. BMC Cancer. 2014;14:171.","journal-title":"BMC Cancer."},{"issue":"2","key":"2063_CR44","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/02813432.2021.1922831","volume":"39","author":"ML Ladegaard Baun","year":"2021","unstructured":"Ladegaard Baun ML, Dueholm M, Heje HN, Hamilton W, Petersen LK, Vedsted P. Direct access from general practice to transvaginal ultrasound for early detection of ovarian cancer: a feasibility study. Scand J Prim Health Care. 2021;39(2):230\u20139.","journal-title":"Scand J Prim Health Care."},{"issue":"9","key":"2063_CR45","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.ejca.2013.01.025","volume":"49","author":"ML T\u00f8rring","year":"2013","unstructured":"T\u00f8rring ML, Frydenberg M, Hansen RP, Olesen F, Vedsted P. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care. Eur J Cancer. 2013;49(9):2187\u201398.","journal-title":"Eur J Cancer."},{"key":"2063_CR46","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12885-015-1317-7","volume":"15","author":"H Jensen","year":"2015","unstructured":"Jensen H, T\u00f8rring ML, Olesen F, Overgaard J, Fenger-Gr\u00f8n M, Vedsted P. Diagnostic intervals before and after implementation of cancer patient pathways - a GP survey and registry based comparison of three cohorts of cancer patients. BMC Cancer. 2015;15:308.","journal-title":"BMC Cancer."},{"issue":"3","key":"2063_CR47","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/02813432.2020.1794415","volume":"38","author":"K Holtedahl","year":"2020","unstructured":"Holtedahl K. Challenges in early diagnosis of cancer: the fast track. Scand J Prim Health Care. 2020;38(3):251\u20132.","journal-title":"Scand J Prim Health Care."},{"key":"2063_CR48","doi-asserted-by":"crossref","unstructured":"Thulesius H, Sand\u00e9n U, Petek D, Hoffman R, Koskela T, Oliva-Fanlo B, et al. Pluralistic task shifting for a more timely cancer diagnosis. A grounded theory study from a primary care perspective. Scand J Prim Health Care. 2021;39(4):486-97.","DOI":"10.1080\/02813432.2021.2004751"},{"key":"2063_CR49","doi-asserted-by":"publisher","first-page":"m4261","DOI":"10.1136\/bmj.m4261","volume":"371","author":"A Parmar","year":"2020","unstructured":"Parmar A, Chan KKW. Prioritising research into cancer treatment delays. Bmj. 2020;371:m4261.","journal-title":"Bmj."},{"key":"2063_CR50","doi-asserted-by":"crossref","unstructured":"Feinstein AR, Pritchett JA, Schimpff CR. The epidemiology of cancer therapy. IV. The extraction of data from medical records. Arch Intern Med. 1969;123(5):571-90.","DOI":"10.1001\/archinte.123.5.571"}],"container-title":["BMC Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12875-023-02063-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12875-023-02063-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T09:04:53Z","timestamp":1682499893000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/s12875-023-02063-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2063"],"URL":"https:\/\/doi.org\/10.1186\/s12875-023-02063-z","relation":{},"ISSN":["2731-4553"],"issn-type":[{"value":"2731-4553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,26]]},"assertion":[{"value":"11 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Committee for Medical and Health Research Ethics of Northern Norway (REK North) approved the survey protocol (Ref 2010\/1056\u20134). Informed consent from individual patients was waived by REK North, and thus not obtained. No personal identifiable information was attached to the data, and no patients were to be contacted. Personal data were limited to sex, date of birth and type of cancer. Only the individual GP knew the identity of any single patient. Favourable ethical approval was thereafter obtained in the other five participating countries.All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}